← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tiba Biotech, Llc
Cambridge, MA
$4,161,193
Total funding
5
Grants
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,161,193 · 5
By mechanism
R44$2,898,030 · 1
R43$1,263,163 · 4
Investigators at Tiba Biotech, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$966,637
R44 · FY2023 · AI
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$965,715
R44 · FY2025 · AI
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$965,678
R44 · FY2024 · AI
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy$399,300
R43 · FY2025 · CA
Low-dose RNA vaccine platform for tickborne flaviviruses$300,000
R43 · FY2022 · AI
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$284,906
R43 · FY2022 · AI
RNA-based multi-antigen vaccine for SARS-CoV-2$278,957
R43 · FY2021 · AI